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Abstract
Low-to-moderate levels of reactive oxygen species (ROS) govern different steps of neurogenesis via molecular pathways
that have been decrypted only partially. Although it has been postulated that redox-sensitive molecules are involved in
neuronal differentiation, the molecular bases for this process have not been elucidated yet. The aim of this work was
therefore to study the role played by the redox-sensitive, multifunctional protein APE1/Ref-1 (APE1) in the differentiation
process of human adipose tissue-derived multipotent adult stem cells (hAT-MASC) and embryonic carcinoma stem cells (EC)
towards a neuronal phenotype. Methods and results: Applying a definite protocol, hAT-MASC can adopt a neural fate.
During this maturation process, differentiating cells significantly increase their intracellular Reactive Oxygen Species (ROS)
levels and increase the APE1 nuclear fraction bound to chromatin. This latter event is paralleled by the increase of nuclear
NF-kB, a transcription factor regulated by APE1 in a redox-dependent fashion. Importantly, the addition of the antioxidant
N-acetyl cysteine (NAC) to the differentiation medium partially prevents the nuclear accumulation of APE1, increasing the
neuronal differentiation of hAT-MASC. To investigate the involvement of APE1 in the differentiation process, we employed
E3330, a specific inhibitor of the APE1 redox function. The addition of E3330, either to the neurogenic embryonic carcinoma
cell line NT2-D1or to hAT-MASC, increases the differentiation of stem cells towards a neural phenotype, biasing the
differentiation towards specific subtypes, such as dopaminergic cells. In conclusion, during the differentiation process of
stem cells towards a neuroectodermic phenotype, APE1 is recruited, in a ROS-dependent manner, to the chromatin. This
event is associated with an inhibitory effect of APE1 on neurogenesis that may be reversed by E3330. Therefore, E3330 may
be employed both to boost neural differentiation and to bias the differentiation potential of stem cells towards specific
neuronal subtypes. These findings provide a molecular basis for the redox-mediated hypothesis of neuronal differentiation
program.
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Introduction
APE1/Ref-1 (Apurinic apyrimidinic Endonuclease/Redox ef-
fector factor 1, also called APEX1 or Ref-1 and here referred to as
APE1) the mammalian ortholog of E. coli Xth (Exo III), is a master
regulator of cellular response to oxidative stress and plays a central
role in the maintenance of genome stability and transcriptional
regulation. Upon removal of the damaged base, APE1 cleaves the
abasic site to facilitate DNA repair. The vital effects of APE1
appear to depend on its role in the base excision repair pathways
of DNA lesions [1]. However, APE1 also has another major
cellular function, since it works as a reduction-oxidation (redox)
factor and stimulates the DNA binding activity of several
transcription factors that are involved in cell proliferation and
differentiation. This function is accounted for by the redox
sensitive Cys65. This effect is obtained as a redox co-activation of
different transcription factors both involved in cellular response to
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oxidative stress, such as Nuclear Factor-kappaB (NF-kB), Early
growth response protein-1 (Egr-1), p53, Hypoxia-inducible factor
1-alpha (HIF-1a), cAMP response element-binding protein
(CREB), activator protein 1 (AP-1) and in differentiation programs
such as Paired box containing proteins (Pax) in different cell
systems [2]. Recent in vitro studies showed that APE1 adopts
different unfolded conformations depending on the redox state of
its Cys residues, in particular C65 and C93 [3]; moreover, the
APE1 redox inhibitor (E)-3-(2-(5,6-dimethoxy-3-methyl-1,4-ben-
zoquinonyl))-2-nonyl propenoic acid (E3330) was shown to
decrease the amount of the redox-active protein by driving C65
into disulfide bonds. E3330 holds clinical potential as a specific
inhibitor of APE1 redox function, without interfering with its
endonuclease activity (for reviews see [4,5]). The importance of
this function is highlighted by results demonstrating that NF-kB-
mediated gene expression is regulated by APE1 redox activity,
without effects on IkBa degradation [6,7]. E3330 was also found
to selectively inhibit growth/migration of human pancreatic
cancer cells [8], suggesting that the APE1 redox function could
represent a good candidate for inhibition of tumor invasion and
metastasis. We recently demonstrated that E3330-treatment
inhibits the TNFa-induced IL8 production driven by NF-kB, in
hepatic cancer cell lines [9]. However, knowledge on the detailed
molecular mechanisms responsible for the C65-mediated APE1
redox function and for the effects of E3330 inhibition on APE1
in vivo are only at its beginning. We recently provided evidence
that this redox regulation of APE1 may impact on protein
subcellular mitochondrial trafficking [10]. In this regard, the
specific block of APE1 redox activity on NF-kB with E3330
impairs hemangioblast development in vitro [11], thus confirming
the leading role of APE1 redox function in affecting the cell
differentiation programs. A third non-canonical and poorly
characterized APE1 function is represented by its transcriptional
activity mediated by direct binding of APE1 to the negative calci-
um response elements (nCaRE) [12,13] present on different pro-
moters, including parathormone (PTH), APE1, Bcl-2-associated X
protein (Bax) and sirtuin 1 (SIRT1)10, 11 (Antoniali et al., MBoC in Press).
The two major functions of APE1, redox and base-excision repair,
are completely independent. In fact, the N-terminus, which
contains the nuclear localization signal sequence (NLS), is
principally devoted to redox-mediated transcriptional co-activa-
tion activity and promotes, through its lysine residues, the ability of
APE1 to interact both with nucleic acids and with nucleophosmin
[14], while the C-terminus exerts the enzymatic activity on the
abasic sites of DNA mainly through the residue H309 in the
catalytic site [15]. Furthermore, a new unsuspected function of
APE1 in RNA metabolism, which is controlled by the N-terminal
domain of the protein, has been recently discovered. In particular,
it has been demonstrated that APE1 acts as a cleansing factor of
abasic rRNA and is able to bind hairpin structures of RNA
molecules [16,17].
APE1 is essential for cell viability [18] and therefore a detailed
comprehension of the molecular targets of APE1 functions has
been very difficult. Conditional knock-out and knock-down
strategies [1,19] confirmed the essentiality of this protein and
allowed establishment of cell models to inspect and characterize, in
better detail, the major functions of APE1. However, knowledge of
the molecular effectors regulated by APE1 in determining its
biological essentiality is still scanty.
Concerning the role played by APE1 on neuronal cells, it
seems to be essential both in protecting cells toward oxidative
stress and in controlling the differentiation program. In fact, it
has been demonstrated that APE1 promotes NF-kB-driven glial
cell-derived neurotrophic factor (GDNF) receptor a1 expression,
thus inducing GDNF responsiveness, which subsequently both
stimulates neurite outgrowth and protects cells from amyloid
peptide and oxidative stress [20]. GDNF was originally
characterized as a potent neurotrophic factor, specific for the
survival and differentiation of the midbrain dopaminergic
neurons [21]. Interestingly, APE1 is highly expressed, in vivo,
in selected regions of the central nervous system [22,23]
supporting its pivotal role for neuronal cells. In pathological
settings, a reduction in APE1 expression has been shown to
occur: in the hippocampus after hypoxic/ischemic injury [24],
in the cortex after compression injury [25], and in the spinal
cord after ischemia [26], while increased nuclear levels have
been described in Alzheimer’s disease cerebral cortex, corrob-
orating the view that the cellular adaptive response to the
oxidative stress condition is involved in the pathogenesis of this
disease [27].
However, the role played by APE1 in the differentiation of
either embryonic or adult stem cells towards the neural and glial
lineages has not been investigated thus far. To this aim, we
employed two distinct cell systems: 1) a human Embryonic
Carcinoma cell line (hEC) that possesses a well-established ability
to differentiate towards a neural fate (NTERA2 cl.D1 -NT2-D1-)
[28] and 2) non-immortalized human adult stem cells. Specifically,
we isolated and cultured Multipotent Adult Stem Cells (MASC)
from adipose tissue, modifying a culture protocol that we already
used to isolate similar cells from adult human bone marrow, heart,
liver and skin biopsies [29–31]. MASC display clonogenicity, self-
renewal ability, and multipotency, express pluripotent state
specific transcription factors (i.e. OCT4, Nanog, Sox2, and
Rex1), display high levels of telomerase activity, and a gene
expression profile highly similar, irrespectively from the tissue of
origin [29]. Most importantly, MASC can differentiate into
neuron-like cells that display, on top of markers of cell
differentiation, functional properties of neuronal cells [29].
The goal of the present study was to evaluate the potential role
played by the APE1 redox function in the differentiation process of
stem cells towards a neuronal fate.
Materials and Methods
Tissue Donors and Ethical Approval
Human adipose tissue samples of healthy donors (n = 31)
undergoing plastic surgery were collected after informed consent.
The study was approved by the Ethics Committee of Udine
(reference number 47831) and a written consent was obtained
from each enrolled subject.
Culture and Differentiation of NT2-D1
NTERA-2 cl.D1 (NT2-D1) cells were purchased from Istituto
Zooprofilattico di Lombardia ed Emilia (IZSLER) cultured in
Dulbecco’s modified Eagle’s medium (high glucose) containing
10% fetal bovine serum (FBS), 4 mM glutamine and 1%
Penicillin/Streptomycin. For neuronal differentiation, NT2-D1
cells were cultured for four weeks in Opti-MEM containing 4%
FBS, 4 mM glutamine, 56 mM b-mercapto-ethanol, 1% Penicil-
lin/Streptomycin and 100 mM all-trans retinoic acid (ATRA).
Following ATRA treatment cells were split 1:6. After 1–2 days
cultures were mechanically shaken to dislodge cells and these free-
floating cells were plated onto Matrigel (50 mg/ml) coated growth
surface and treated for two weeks with 10 mM fluorodeoxyuridine,
10 mM uridine and 1 mM cytosine arabinoside. For the inhibition
of APE1, E3330 [20 mM] was added to the culture medium
starting from the third week of differentiation.
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Human Adipose Tissue Derived MASCs (hAT-MASCs)
After tumescent liposuction, lipoaspirates were centrifuged at
36103 g for 3 minutes and the stromal vascular fraction was
collected in a sterile container. The samples were enzymatically
dissociated in a 0.05% Collagenase type II solution (Sigma-
Aldrich) in Joklik modified Eagle’s Medium (Sigma-Aldrich) for 20
minutes at 37uC. Collagenase activity was stopped by the addition
of 0.1% BSA (Sigma-Aldrich) solution in Joklik modified Eagle’s
Medium (Sigma-Aldrich). Cell suspension was centrifuged at
16103 g for 10 minutes. Samples collected from different subjects
were kept distinct and used to obtain distinct hAT-MASC cell
lines.
2.06106 freshly isolated human cells were plated onto 100 mm
human fibronectin (Sigma-Aldrich) coated dishes (BD Falcon) in
an expansion medium composed as follows: 60% low glucose
DMEM (Invitrogen), 40% MCDB-201, 1 mg/mL linoleic acid-
BSA, 1029 M dexamethasone, 1024 M ascorbic acid-2 phosphate,
1X insulin-transferrin-sodium selenite (all from Sigma-Aldrich),
2% fetal bovine serum (StemCell Technologies), 10 ng/ml human
or murine PDGF-BB, 10 ng/ml human or murine EGF (both
from Peprotech EC). Medium was replaced with fresh one every 4
days. Once cells reached 70–80% of confluence, they were
detached with 0.25% trypsin-EDTA (Sigma-Aldrich) and re-
plated at a density of 1–26103/cm2.
Flow Cytometry
At passage 3 (P3), cells grown in expansion medium were
detached with 0.25% trypsin-EDTA (Sigma-Aldrich) and, after a
20 minutes recovery phase, were incubated with the following
properly conjugated primary antibodies: CD10, CD13, CD29,
CD49a, CD49b, CD49d, CD90, CD73, CD44, CD59, CD45,
HLA-DR, CD117, CD34, CD 271 (BD Biosciences), CD105,
CD66e, KDR (Serotech), CD133 (Miltenyi Biotec), CXCR4
(R&D), ABCG-2 (Chemicon International).
Single Cell Cloning
P2 cells were individually deposited onto the wells of a 96wells
Terasaki plate with an automated cell sorter (MoFlo, DakoCyto-
mation) and cultured in expansion medium, as in [29]. About 700
wells were seeded for each analyzed cell line.
Multilineage Differentiation of hAT-MASC
Multilineage differentiation was induced as in Beltrami et al.
2007.
For neural differentiation, hAT-MASCs were plated at a density
of 36103/cm2 in DMEM-HG, 10% FBS, N1. After 24 hours,
medium was replaced with a medium added with 1% B27
(Invitrogen), 10 ng/ml EGF (Peprotech) and 20 ng/ml bFGF
(Peprotech), N2. After 5 days, cells were washed and incubated for
9 days with DMEM containing 5 mg/ml insulin, 200 mM
indomethacin and 0.5 mM IBMX (all from Sigma-Aldrich) in
the absence of FBS, N3. For experiments involving the use of
antioxidants, 10 mM N-acetyl cysteine was added to the culture
medium, while for experiments requiring the inhibition of APE1
redox function, the specific inhibitor E3330 was employed (kindly
provided by Prof. M.R. Kelley) [4]. Specifically, in hAT-MASC
cultures E3330 was either added at a concentration of 20 mM
during the last step of the differentiation protocol (N3) or at a
concentration of 40 mM and 20 mM during the last two steps of the
differentiation protocol (N2 and N3, respectively).
Measurement of Intracellular Reactive Oxygen Species
(ROS) Generation
Following the manufacturer’s protocol, cells were loaded with
5 mM 5–[and -6]-chloromethyl–29,79-dichlorodihydrofluorescein
diacetate acetyl ester (CM-H2DCFDA, Molecular Probe, Eugene,
OR, USA) for 15 minutes, protected from light, in Opti-MEM
(Invitrogen). Then, 1 mM H202 was added for 30 minutes as
positive control. The cells were washed once with PBS and the
production of ROS was visualized by inverted fluorescence
microscope and images were quantified by ImageJ software.
Protein Extraction
To prepare the total protein extracts, 26106 cells were lysed in
50 mM Tris-HCl pH 7.5; 150 mM NaCl; 1 mM EDTA, 1%
Triton X-100 containing a cocktail of protease inhibitor (Sigma-
Aldrich), 0.5 mM PMSF, 1 mM NaF, 1 mM Na3VO4 and
0.1 mM DTT). The suspension was then incubated at 4uC for
30 minutes, sonicated and then subjected to centrifugation for 20
minutes at 120006g. The supernatant was collected as total
extract and stored at 280uC for biochemical assays.
To separate the soluble (S1) and insoluble (P1) fractions cells
pellets (36106cells) were incubated for 10 min at 4uC under
orbital rotation in 200 ml ice-cold CSK buffer (100 mM NaCl,
300 mM sucrose, 10 mM PIPES, pH 6.8, 3 mM MgCl2, 1 mM
DTT, 1 mM EGTA) containing 0.5% Triton X-100 and protease
inhibitors. After centrifugation at 50006g for 5 min, the
supernatant (soluble proteins) was recovered (S1 fraction). Pellets
were washed three times with 1 ml ice-cold CSK and centrifuged
at 5,0006g for 5 min. The resulting pellets (P1, chromatin
fraction) were resuspended in 30 ml of 20 mM Tris-HCl buffer,
pH 8, 150 mM NaCl, 0.1% NP40, 1 mM EDTA and protease
inhibitors. The suspension was sonicated and centrifuged for 30
min at 13,0006g at 4uC and the supernatant was recovered.
Protein content was measured using a colorimetric Bradford assay
(Bio-Rad Laboratories, Richmond, CA) with bovine serum
albumin as a standard.
Western-blot Analysis
Loading of the extracts was normalized by protein content.
Aliquots from the cell extracts were denatured by heating at 95uC
for 5 min. Samples were electophoresed on 10% SDS-PAGE and
then transferred to nitrocellulose membranes as previously
described [32]. To confirm the amounts of protein in each lane,
membranes were stained with Ponceau rouge, and a second gel
was run in parallel and stained with Comassie. Blots were
incubated with the following antibodies: mouse monoclonal anti-
APE1 antibody (kindly provided by Prof. M.R. Kelley), and rabbit
antibody anti-actin (Sigma) to normalize the protein content in the
total extracts; then with the corresponding peroxidase–conjugated
anti-serum (Sigma). The bands were visualized and analyzed using
a ChemiDoc XRS (Bio-Rad, Milano, Italy) and associated
software.
Immunofluorescence Confocal Analysis
Cells fixed in 4% (wt/vol) paraformaldehyde for 20 min at
room temperature were permeabilized for 5 min with PBS–0.25%
(wt/vol) Triton X-100 and incubated for 30 min with 5% normal
donkey serum in PBS–0.1% (wt/vol) Triton X-100 (blocking
solution) to block unspecific binding of the antibodies. Cells were
then incubated with the following antibodies: OCT-4, Sox2 and
Nanog to evaluate primitive cell transcriptional settings; GATA4,
cytokeratin 8-18-19, smooth muscle actin (SMA), connexin43,
alfa-sarcomeric actin (ASA), glial fibrillary acidic protein (GFAP),
APE1 Redox Function in Neural Differentiation
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b3 tubulin, Microtubule Associate Protein2 (MAP2), and Basic
Myelin Protein to evaluate multilineage differentiation (Table S1).
To evaluate the role of APE1 in neuronal differentiation, cells
were incubated for 3 h with a mouse monoclonal antibody [32],
previously labeled by using the Zenon Mouse IgG Labeling Kit
(Molecular Probes), utilizing the Alexa Fluor 488-labeled Fab
fragment directed against the Fc portion of the IgG primary anti-
APE antibody, in accordance to instructions, diluted 1:2 in
blocking solution alone, or together with anti NFkB p65 rabbit
polyclonal antibody 1:100 (Santa Cruz Biotechnology, CA, USA).
In this case, after washing cells were incubated for 90 min with
secondary Alexa Fluor 546 conjugated goat anti rabbit antibody.
Nuclei were then counterstained by DAPI (Sigma), and the
microscope slides mounted and visualized through a Leica TCS
SP laser-scanning confocal microscope (Leica Microsystems,
Wetzlar, Germany) equipped with a 488-nm argon laser, a 543-
nmHeNe laser, and a 63x oil fluorescence objective.
Quantitative Analysis of Immunofluorescence
To obtain quantitative data of the nuclear levels of APE1,
images of immunofluorescently labeled cells were acquired with a
fully automated dedicated imaging system (DMI6000B, Leica
Microsystems or BD Pathway 850, Becton Dickinson). Scrupulous
care was taken to keep constant both the exposure time and gain
of the camera, and to set these parameters in order to avoid image
saturation. Images of APE1 were taken before acquiring DAPI
images and an internal shutter was employed to avoid unnecessary
exposure of the specimen to light, thus minimizing photobleaching
effects. A quantitation of the total fluorescence of nuclear APE1
staining was obtained employing ImageJ software [33]. A
threshold was applied to DAPI images both to measure nuclear
areas and to create a mask to measure the average intensity of
APE1 fluorescence. APE1 Integrated Fluorescence Intensity (IFI)
was computed for each nucleus multiplying each nuclear area for
the respective mean grey value of APE1.
Real-Time RT-PCR
Total RNA was extracted from both non-confluent cultures of
undifferentiated and differentiated cells at P3 using the TRIzol
Reagent (Invitrogen). After treatment with DNase I (Ambion), first
strand cDNA synthesis was performed with 1 mg total RNA using
random hexanucleotides and MMLV reverse transcriptase (In-
vitrogen). Primers were designed from available human sequences
using the primer analysis software Primer3 (Table S2). Quantita-
tive RT-PCR was performed using Roche LightCycler 480 Real-
Time PCR System and the LightCycler 480 SYBR Green I
Master (Roche), following manufacturer’s instructions. HPRT was
used as internal control for normalization. LightCycler 480 Basic
software (Roche) utilized the second derivative maximum method
to identify the crossing point (Cp).
Statistics
Characteristics of the study population are described using
means6SEM. Data were analyzed for normal distribution by
Kolmogorov-Smirnov test. T-test or Mann-Whitney test, as
appropriate, was used to compare continuous variables between
two groups. Drug-treatment assays were analyzed by repeated
measurements one-way Anova followed by Bonferroni post-test or
by Friedman test followed by Dunn’s post-test, as appropriate.
Probability values (p) less than 0.05 were considered significant.
Analyses were conducted with Prism, version 4.0c and SPSS20 for
Macintosh software.
Results
Neuronal Differentiation of EC and Adult Stem Cells
To dissect the role played by APE1 on neuronal differentiation,
we first used NT2-D1, a human teratocarcinoma cell line that can
generate central nervous system neurons [28]. To induce their
differentiation towards a neural fate, we adopted a protocol that
involved the use of retinoic acid (ATRA) treatment for four
consecutive weeks, followed by the incubation of the cells for two
additional weeks in retinoic acid-free medium (Figure 1A). To
verify the level of differentiation reached by NT2-D1, cells were
characterized at the gene and protein expression levels. After one
week of exposure to ATRA, NT2-D1 cells significantly down-
regulated Nanog, Nestin and Sox2, representing markers of an
undifferentiated state. This latter transcription factor, however,
was still expressed at low levels by a large fraction of cells, being
typically expressed by neuronal progenitors (Figure S1). Neuronal
commitment and differentiation was evaluated by immunofluo-
rescence and by realtime PCR, through which we analyzed
transcripts of genes typically expressed by specific cell subtypes
(Figure S2). Quantitatively, differentiated cells showed a significant
increase in transcripts for glutamate decarboxylase (GAD1, a
marker of GABAergic neurons), acetylcholinesterase (ACHE, a
marker of cholinergic neurons), dopamine transporter (DAT,
expressed by dopaminergic neurons), vesicular glutamate trans-
porter1 (VGLUT1, marker of glutamatergic neurons) and
Glutamate receptor subunit epsilon-1 (GRIN2a) (Figure 1B).
Concomitantly, NT2-D1 cells significantly increased their positiv-
ity to MAP2 and GFAP, known markers of neural and glial cells,
respectively. These proteins became organized showing a
filamentous pattern starting from the third week of differentiation
(Figure 1C).
As a second cellular model, we employed primary human
Multipotent Adult Stem Cells isolated from adipose tissue (hAT)
samples [31], adapting to this tissue the method that we previously
used to generate these cells from human liver, heart, bone marrow,
and skin biopsies [29,30]. Briefly, we generated 31 plastic
adherent, proliferating cell lines from adipose tissue samples with
very high efficiency. After three passages in culture, hAT-derived
cell lines were characterized to check the acquisition of MASC
features. Adipose-tissue derived cell lines showed a mesenchymal
cell surface immunophenotype (Figure 2A), expressed the
transcription factors Oct-4, NANOG and SOX2, were clonogenic
and multipotent (Figure 2B). In order to induce hAT-MASC
differentiation towards a neuronal fate, a three-step protocol was
employed. hAT-MASC were first exposed to a high serum culture
medium (N1) for one day, and subsequently to EGF and bFGF for
5 days (N2). At the end of this commitment period, cells were
maintained in a serum-free medium containing insulin, indometh-
acin, and IBMX for 2–5 days (N3). During this last step cells
displayed a remarkable morphological change: starting from a
flattened and polygonal shape, their cytoplasm retracted towards
the nucleus, leaving long cellular processes peripherally
(Figure 2C). Quantitatively, differentiated cells showed, with
respect to undifferentiated hAT-MASCs (n= 6), a significant
increase in transcripts for myelin basic protein (MBP), glial
fibrillary acidic protein (GFAP), Grin2A, choline acetyltransferase
(CHAT), acetylcholinesterase (ACHE), and dopamine transporter
(DAT), suggesting a stochastic maturation of primitive cells
towards different neuronal and glial phenotypes (Figure 2D).
Altogether these results demonstrated that we could obtain cells
with similar neuronal properties from both adult and EC stem
cells.
APE1 Redox Function in Neural Differentiation
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Figure 1. All-Trans Retinoic Acid (ATRA) induces neuronal
differentiation of NT2-D1 cells. (A) Phase contrast images of NT2-
D1 cells exposed to ATRA taken during the 1st, 3rd, 4th and 6th week of
differentiation. (B) Histograms showing the relative expression of
transcripts of markers of specific neuronal subtypes in differentiated
NT2-D1 cells (VI week) versus undifferentiated cells. (C) Immunofluo-
rescence images of undifferentiated (upper panels) and NT2-D1 cells
exposed to the differentiation protocol for 6 weeks (VI week). GFAP and
MAP2 were tested as markers of neural and glial lineages. Histograms
represent the fraction (%) of cells positive to the tested markers during
the differentiation period. Nuclei are stained in blue by 49,6-diamidino-
2-phenylindole (DAPI). Arrows indicate when, during the differentiation
protocol, immunoreactive filaments were first observed. *, **, ***, ****
p,0.05 vs I, II, III, and IV column, respectively.
doi:10.1371/journal.pone.0089232.g001
Figure 2. Characterization and neuronal differentiation of
human adipose-tissue derived Multipotent Adult Stem Cells
(hAT-MASC). (A) Representative flow cytometry histograms of a hAT-
derived multipotent stem cell population. Plots show isotype control
IgG-staining profile (green histogram) versus specific antibody staining
profile (red histogram). hAT-MASCs express high levels of mesenchymal
APE1 Redox Function in Neural Differentiation
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Reactive Oxygen Species (ROS)-dependent Nuclear
Translocation of APE1 during Neuronal Differentiation
With the aim of exploring the involvement of ROS and APE1 in
the differentiation of stem cells towards a neuronal fate, we first
exposed hAT-MASC to the differentiation protocol and analyzed
intracellular ROS levels. As shown in figures 3A–D, intracellular
ROS significantly increased upon differentiation. This effect was
abrogated, at least in part, by the addition of the ROS scavenger
N-acetyl cysteine (NAC) to the culture medium. Quantitative
immunofluorescence analysis of APE1 showed a similar trend
(Figure 3E–K). Specifically, in non-differentiated cells (from
undifferentiated to N2), APE1 was predominantly localized to
the nucleus, while there was a significant increase in the nuclear
content of the protein in N3, the most differentiated stage. The
addition of NAC during the differentiation stage partially
abolished this latter event (Figure 3K).
We then tested whether the observed nuclear increase was
accompanied by a parallel increase in protein expression. As
shown in (Figure 3L), testing APE1 expression in total protein
extracts, we were not able to demonstrate the occurrence of any
significant increase in total expression concomitant to the
proceeding of differentiation. This was confirmed by RT-PCR
experiments (data not shown), suggesting that the increase of
APE1 in the nucleus was dependent on a nuclear accumulation of
the protein rather than on a mere change in the expression levels.
We then analyzed the amount of APE1 bound to insoluble
chromatin fraction, by performing a biochemical extraction
protocol. The soluble protein fraction (S1) was recovered by
extracting cells with CSK buffer. The resulting cell pellet (P1)
corresponded to the proteins bound to DNA. Using these
extraction conditions, we demonstrated a two fold increase in
the expression of APE1 bound to DNA in the N2 and N3 stages
compared to the non-differentiated (Control) or proliferating cells
(N1) (Figure 3M).
The increase of APE1 bound to chromatin suggested the
existence of a correlation with an increase of its DNA-related
functions (i.e. both repair and/or transcriptional activities).
Therefore, we tested whether this observation could correlate
with the functional activity of NF-kB, a well-known transcriptional
factor regulated by APE1. As expected, we observed a nuclear
accumulation of p65-NF-kB, which correlated with the increase in
the intensity of APE1 nuclear fluorescence (Figure 3N, O).
APE1 Redox Function Drives the Neuronal Fate of
Differentiating Stem Cells
Last, we studied the involvement of APE1 in the neuronal
differentiation of both adult and EC stem cells.
stem cell markers (CD90, CD73, CD44, while they are negative for
hematopoietic markers CD45 and CD34). (B) Immunofluorescence
images of undifferentiated and differentiated hAT-MASC. Undifferenti-
ated cells express the pluripotent state specific transcription factors
Oct4 (green), Nanog (purple) and Sox2 (yellow). When exposed to
neural differentiation medium these cells express the neural markers ß3
tubulin (TUBB3, green) and acetylcholinesterase (ACHE, brown). Once
induced to differentiate into hepatocytes, hAT-MASC uptake acetylated
LDL (AcLDL, red). Once exposed to myogenic or endothelial media,
these cells express either alpha-sarcomeric actin (ASA, red), smooth
muscle actin (SMA, purple) or PE-CAM (CD31, green). Nuclei are stained
by DAPI (blue). (C) Phase contrast images of undifferentiated and
differentiated hAT-MASC. (D) Histograms showing the relative expres-
sion of transcripts of neuronal and glial markers in differentiated hAT-
MASC cells (N3, red histogram) versus undifferentiated cells (blue
histogram).
doi:10.1371/journal.pone.0089232.g002
Figure 3. Differentiation towards a neuronal fate increases
both intracellular ROS levels and the nuclear localization of
APE1. (A–D) Epifluorescence images of undifferentiated (undiff, A),
and differentiated hAT-MASC cultured either in the absence (N3, B) or in
the presence (N3+NAC, C) of NAC. The ROS sensitive, green fluorescent
dye CM-H2DCFDA was used to quantitate intracellular ROS levels.
Histograms (D) show the quantification of the Integrated Fluorescence
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For this purpose, we first evaluated the impact exerted by the
addition of NAC to the neural differentiation media of hAT-
MASC. As shown in figure 4A-B, the morphology of cells reaching
the end of the differentiation period was dramatically affected by
the antioxidant treatment. Additionally, NAC significantly in-
creased the fraction of differentiated cells expressing the neuronal
marker MAP2, without affecting the expression of the glial marker
MBP (Figure 4C–J).
Based on these data, we investigated the role of APE1 redox
function on neuronal differentiation using an APE1 specific redox
inhibitor E3330. For this purpose, we first assessed the toxicity of
E3330 on hAT-MASCs, exposing these cells either during the last
step (N3) or during the last two steps of the differentiation protocol
(N2 and N3). E3330, at a dose ranging from 10–100 mM, had no
apparent effect on undifferentiated hAT-MASC viability, as
assessed by MTT assay (Figure 5A), while its addition to
differentiating cells significantly affected cell yield (Figure 5B).
Therefore, for subsequent studies, we employed a dose and
administration scheme that balanced E3330 toxicity with its effects
on APE1. Interestingly, the addition of E3330 during the first day
of incubation with N3 medium significantly increased nuclear
levels of APE1, as detected by quantitative fluorescence imaging
(Figure 5C, D). On the contrary, when E3330 was added during
the entire differentiation period, we observed a significant decrease
in APE1 nuclear levels (Figure 5C, D).
The addition of E3330 during the differentiation protocol,
significantly increased transcripts associated with neuronal differ-
entiation; specifically, with respect to differentiated hAT-MASCs
not exposed to E3330, the exposed ones up-regulated the
transcripts for the neuronal markers NeuroD2 and MAP2
(Figure 6A). Furthermore, E3330-treatment increased the expres-
sion of markers of cholinergic (CHAT), and dopaminergic (DAT)
neurons (Figure 6A). Last, cells exposed to E3330 showed an
increase in immunoreactivity against both MAP2 and MBP
(Figure 6B).
Similar results were also obtained exposing the cell line NT2-D1
to E3330 starting from the 3rd week of differentiation. Specifically,
with respect to the non-treated ones, E3330-treated cells expressed
significantly higher levels of GAD1, ACHE, and DAT. On the
contrary, Vesicular glutamate transporter 1, and Grin2A were not
up-regulated by the inhibition of APE1 redox function (Figure 7A).
Last, E3330-treatment significantly increased the immunoreactiv-
ity of differentiated cells against MAP2, while it had no effect on
GFAP (Figure 7B, C).
Intensity (IFI) of the above-described groups in 3 (I–III) independent
hAT-MASC lines. (E–G) Immunofluorescence images of APE1 (red) in
undifferentiated, N3, and N3+NAC groups. (H–J) Nuclear localization of
APE1 is shown superimposing to the above images, the blue
fluorescence of DAPI staining. APE1 expression was quantified in the
three groups by analyzing the IFI of APE1 nuclear fluorescence.
Histograms (K) summarizing data for APE1 nuclear quantitative
fluorescence. (L) Representative Western blot of APE1. 10 mg of total
protein extracts were loaded onto a 10% SDS-PAGE, blotted and
incubated with the APE1 primary antibody and horseradish peroxidase-
conjugated secondary antibody. Numbers at the bottom were obtained
from densitometric analysis of three independent experiments,
normalized versus actin. (M) Cells in the different stages of differen-
tiation were separated into fractions S1 (soluble proteins) and P1
(proteins bound to DNA). Equivalent amounts were analyzed by
western blot with antibody against APE1. Numbers at the bottom were
obtained from densitometric analysis of three independent experi-
ments, normalized versus a gel run in parallel and stained with
Comassie. (N, O) Immunofluorescence images showing colocalization
of APE1 (red) with the p65 subunit of NFkB (green) obtained both in
undifferentiated and differentiated (N3) hAT-MASC. Cells comprised in
the square are shown at higher magnification in the panels localized at
the right side of each picture, where the contribution of APE1 and NFkB
are shown as separate images. *, ** p,0.05 vs Undifferentiated or N3
cells, respectively.
doi:10.1371/journal.pone.0089232.g003
Figure 4. Impact exerted by ROS on the differentiation of adult
stem cell towards a neural fate. (A, B) Contrast phase images of
hAT-MASC differentiated in the absence (A) or in the presence (B) of
NAC. Fluorescence images showing MBP (C, green) and MAP2 (G, red)
expression in undifferentiated hAT-MASC and in hAT-MASC differenti-
ated either in the absence (D, H) or presence of NAC (E, I). Histograms
(F, J) represent the fraction of cells positive for MBP or MAP2. n = 3
distinct hAT-MASC lines; *, ** p,0.05 vs Undifferentiated or N3 cells,
respectively.
doi:10.1371/journal.pone.0089232.g004
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Figure 5. Effects of E3330 on cell viability, proliferation and
APE1 expression. (A) Histograms summarizing the results of a
viability assay (MTT) performed following the exposure of undifferen-
tiated hAT-MASC to either positive control (DMSO), negative control
(untreated), or 10 mM, 25 mM, 50 mM, 75 mM, and 100 mM of E3330. (B)
Histograms summarizing the effects of the exposure of hAT-MASC to
E3330 -during either the last step (N3) or the last two steps (N2N3) of
differentiation- on the yield of cells at the end of the differentiation
protocol. (C) Immunofluorescence images showing the effects the
exposure of hAT-MASC to E3330–during either N3 or N2N3- on APE1
expression (green). Nuclei are blue labeled by DAPI. (D) Quantification
of Ape1 nuclear expression (IFI) is summarized in histograms. *, **, ***,
***** p,0.05 vs I, II, III, and V column, respectively.
doi:10.1371/journal.pone.0089232.g005
Figure 6. E3330 increases the neuronal differentiation of hAT-
MASC. (A) Histograms showing the relative expression of transcripts of
neuronal and glial markers in undifferentiated and differentiated hAT-
MASC, exposed or not to E3330. (B) Immunofluorescence images of
differentiated hAT-MASC that were either not exposed (upper 2 panels)
or exposed (lower 4 panels) to E3330 during the differentiation
protocol. Cells were stained for the glial marker MBP (green) and for the
neuronal marker MAP2 (red). * p,0.05 vs Undifferentiated cells.
doi:10.1371/journal.pone.0089232.g006
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Altogether these results indicate that the redox function of
APE1 regulates stem cell differentiation towards a neurogenic fate,
reducing it and modulating the differentiation towards specific
neuronal subtypes.
Discussion
This work has several aspects of novelty that have been
summarized in Figure 7D: i) APE1 accumulates, in a ROS-
dependent fashion, into the nuclei and associates to the chromatin
of adult stem cells differentiated towards a neuronal fate, ii) the
redox function of APE1 plays a role in the neuronal differentiation
of both adult and embryonic stem cells, and iii) the use of a specific
inhibitor of the redox function of APE1 increases the extent of
neuronal differentiation, facilitating the differentiation towards
specific neuronal subsets.
A growing body of literature obtained on different cell models
(most of which obtained from rodents) has demonstrated that low-
to-moderate levels of ROS govern different steps of neurogenesis,
ranging from progenitor cell proliferation to neuronal differenti-
ation [34]. Consistently, we show in the present work that
intracellular ROS levels significantly increase during the differen-
tiation process of human AT-MASC towards a neural phenotype.
However, we newly demonstrate that the addition of an
antioxidant (NAC) to the culture medium of hAT-MASC may
alter the extent of differentiation of this cell type. To gain insights
into the mechanism involved in this process, we focused our
attention on APE1, since Reactive Oxygen Species (ROS) may
regulate the activity of this multifunctional protein both at the
transcriptional level and at the post-translational one, promoting
its cytoplasmic to nuclear translocation [2]. This latter event,
which is regulated by acetylation of conserved K residues present
in the N-terminal domain of APE1, has been associated to the
functional activation of several target transcription factors [35]. In
line, we found that hAT-MASC exposed to a neural differentiation
protocol are characterized by a progressive nuclear accumulation
of both APE1 and one of its target transcription factors (i.e.
nuclear factor-kB, NF-kB). These events occur in the absence of a
net increase in the total levels of APE1 and are paralleled by a
progressive increase in the abundance of chromatin-bound APE1.
Importantly, NAC can partially reduce the nuclear accumulation
of APE1. Altogether our results support the hypothesized role
played by redox-sensitive transcription factors on neurogenesis
[34].
Given the complete independence of the two major functions of
APE1 (i.e. the repair function and the redox one) [36], we took
advantage of the ability of the drug E3330 to inhibit selectively this
latter, without affecting the first one. Our results demonstrate that
E3330, at a dose ranging from 10–100 mM, is not toxic, when
given to undifferentiated cells. However, the addition of this
compound to the differentiation media of either hAT-MASC or
NT2-D1 significantly increases, in both cell types, the expression
of markers of neuronal differentiation (e.g. MAP2). Altogether
these results suggest that the redox function of APE1 exerts an
inhibitory effect on the maturation of both adult and embryonic
human stem cells towards the neuronal fate. Consistently, several
transcription factors that are regulated by APE1 in a redox-
dependent manner have been implicated in neurogenesis (e.g. p53,
Figure 7. E3330 increases the neuronal differentiation of hAT-
MASC. (A) Histograms showing the relative expression of transcripts of
markers of specific neuronal subtypes in undifferentiated and
differentiated NT2-D1, exposed or not to E3330, at the IV and VI week
of differentiation. (B) Immunofluorescence images of differentiated
NT2-D1 that were either not exposed (upper panels) or exposed (lower
panels) to E3330 during the differentiation protocol. Cells were stained
for the glial marker GFAP (green) and for the neuronal marker MAP2
(red). (C) Histograms summarizing the fraction of cells positive to MAP2
and GFAP at the end of the VI week of differentiation in the absence (2
E3330) or presence (+E3330) of Ape1 inhibition. (D) Diagram
summarizing the main findings of this work on the involvement of
Ape1 in neuronal differentiation. Arrows with blunt ends indicate
inhibition. * p,0.05 vs I column.
doi:10.1371/journal.pone.0089232.g007
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CREB, NF-kB, STAT3, HIF-1a, Egr1, and Pax8). Among these, a
primary inhibitory role on neural differentiation is played by p53.
In fact, p53 deficiency leads to increased neurogenesis, biased
differentiation in vivo and an incremented ex vivo proliferation of
neural stem cells [37,38]. STAT3 too may bias stem cell
differentiation, reducing neurogenesis, as shown by the observa-
tion that neural precursor cells differentiate into astrocytes after
stimulation with CNTF or LIF via STAT3 activation [39,40].
Last, the addition of E3330 to differentiating cells modifies the
expression of markers of specific neuronal subtypes, increasing the
expression of cholinergic, dopaminergic and GABAergic markers.
These results may be consistent with the observed effect of mild
hypoxia on neural progenitor cell differentiation towards a
dopaminergic phenotype [41] or with the effects of pollutants
that increase intracellular ROS levels on the maturation of
GABAergic neurons [42]. Less prominent are the effects observed
on the expression of glutamatergic or serotoninergic markers.
Intriguingly, although NT2-D1 cells may generate rare serotonin-
ergic neurons [43], we observed that SERT expression peaked at a
relatively early time-point (4 weeks) and significantly decreased
after 2 additional weeks of culture. This event may be a
consequence of the mechanical selection of cells that is performed
after 4 weeks of differentiation. However, the addition of E3330
did not affect SERT expression levels at earliest time point.
In conclusion, we have demonstrated that APE1 is involved in
the differentiation of adult and embryonic stem cells towards a
neuronal fate. The inhibition of APE1 redox function, through the
use of the specific inhibitor E3330, demonstrates that this factor
may act by both repressing neuronal maturation and biasing the
differentiation towards specific neuronal subtypes. The majority of
the transcription factors that are regulated by APE1 in a redox-
dependent fashion act mainly favoring progenitor cell proliferation
and differentiation, while p53 and STAT3 exert a repressive effect
on neurogenesis. E3330 may act either inhibiting these latter
factors or shifting stimuli from proliferation to differentiation.
Therefore, this work emphasizes the possible use of pharmaco-
logical strategies, based on modulation of APE1 redox functions,
to boost neural differentiation and bias the differentiation potential
of stem cells towards specific neuronal subtypes. In this regard, the
possibility to employ a small molecule, such as E3330, to increase
the extent of differentiation of stem cells towards a dopaminergic
phenotype is a very attractive one.
Supporting Information
Figure S1 Immunofluorescence images of undifferenti-
ated NT2-D1 cells (upper panels) and NT2-D1 cells
exposed for 1 week to ATRA (lower panels). Typical
markers of undifferentiated cells Nanog (purple), Nestin (green)
and Sox2 (yellow) were tested. Histograms comprised in the mid
box represent the fraction (%) of cells strongly positive to the tested
markers. Histograms contained in the low box show the fraction of
cells either strongly or weakly positive to Sox2.
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